DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Contribución de congreso (ConferenceOutput)
Identification of a functional tryptamine biosynthetic gene cluster encoded on a plasmid in Loigolactobacillus coryniformis IPLA14021
Trabajo presentado en el XXX Congreso de la Sociedad Española de Microbiología, celebrado en Jaén (España), del 16 al 19 de junio de 2025, Loigolactobacillus coryniformis IPLA14021 is a novel tryptamine-producing lactic acid bacteria (LAB) isolated from cheese (1). Tryptamine is a neuromodulator produced by the decarboxylation of L-tryptophan. In humans, it induces serotonin release and can be found in central nervous system and gastrointestinal tract. Furthermore, it is the precursor of important bioactive molecules such as serotonin, melatonin, indole acetic acid or psilocybin. Genetic information in LAB about tryptamine production is scarce -with only one report in Latilactobacillus curvatus (2)- so our objective was to identify the genes involved in tryptamine production in the strain L. coryniformis IPLA14021.
Genome sequencing of the strain allowed the identification of a putative tryptophan decarboxylase, with high similarity to that described in L. curvatus. Furthermore, a L-tryptophan synthase and a DUF554 encoding genes have been found in the surrounding genetic environment. This genetic organisation has been found in genomes of other LAB in the databases, suggesting that they may be forming a biosynthetic gene cluster.
Further analysis showed the presence of the cluster in one of the two plasmids that the strain IPLA14021 harbors. Plasmid curing from the strain generated the two possible variants with a single plasmid and the variant without any plasmid. Those variants without the plasmid containing the tryptamine cluster were unable to produce tryptamine, thus, indicating the functionality of the cluster. This is the first time that a tryptamine biosynthetic cluster is found in a plasmid.
LAB are generally considered safe bacteria and thus, L. coryniformis IPLA14021 could be used to produce tryptamine-enriched functional dairy products, as cell factory, and even as psychobiotic. Moreover, our results open the possibility to use the plasmid harbouring the tryptamine biosynthetic cluster as a genetic tool to optimise the tryptamine production or even to append this functionality to other LAB strains of technological and/or probiotic relevance.
Referencias
(1) Arranz y col. (2025) Food Research International 199: 115380
(2) Irmler y col. (2023) Food Microbiology 116: 104343, This work was funded by the Plan for Science, Technology and Innovation of the Principality of Asturias 2024/2026, co-financed by FEDER (GRU-GIC-24-057) and by MCIN/AEI/10.13039/501100011033
(PID2020‐112629RB‐I00). David Arranz. was the recipient of a predoctoral contract (PRE2021-098772) funded by MCIN/AEI/ 10.13039/501100011033 and by “ESF Investing in your future”., Peer reviewed